Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancer
- 1 June 2003
- Vol. 61 (6) , 1261-1265
- https://doi.org/10.1016/s0090-4295(03)00036-0
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (U01CA86323)
- National Cancer Institute (U01CA86323)
This publication has 13 references indexed in Scilit:
- A structural basis for the unique binding features of the human vitamin D-binding proteinNature Structural & Molecular Biology, 2002
- Mass Spectroscopy as a Discovery Tool for Identifying Serum Markers for Prostate CancerClinical Chemistry, 2001
- Prostate-Specific–Antigen Testing for Early Diagnosis of Prostate CancerNew England Journal of Medicine, 2001
- Prostate-specific antigen best practice policy—part I: early detection and diagnosis of prostate cancerUrology, 2001
- American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001--Testing for Early Lung Cancer DetectionCA: A Cancer Journal for Clinicians, 2001
- Probability-based protein identification by searching sequence databases using mass spectrometry dataElectrophoresis, 1999
- PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOINGJournal of Urology, 1999
- Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide GelsAnalytical Chemistry, 1996
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994
- Vitamin D Binding Protein (Gc-Globulin)*Endocrine Reviews, 1989